Dr Alexandra Davis is a Senior Lecturer in Biomedical Science in the School of Allied Health Sciences. After obtaining her BSc in Biomedical Science she obtained her PhD in Viral Oncology from De 51³Ô¹Ïapp University (UK).
During her PhD, she investigated how Epstein-Barr virus (EBV) Latent Membrane Protein 1 (LMP1) transforms epithelial cells and fibroblasts within the tumour microenvironment (TME). Her findings show that conditioned medium from LMP1-expressing cells induces epithelial-mesenchymal transition (EMT) and fibroblast-to-myofibroblast differentiation, enhancing motility, invasion, and recruitment—effects blocked by TGFβ and ERK/MAPK inhibition. To better model the in vivo TME, she developed a 3D fibroblast culture system, revealing that LMP1-mediated secretions further drive fibroblast invasion. These results highlight LMP1’s role in stromal transformation and tumour metastasis.
Her current research focuses on the development 3D co-culture models to study tumour-stroma interactions and fibroblast-driven drug resistance in breast cancer.
Dr Alexandra Davis is a Fellow of the Higher Education Academy (FHEA) and is also involved in pedagogic research.